Top Buy Now Summary References
Home
>
Section
>
Chapter

Awareness of Being Prescribed Antihypertensive Medications and Cardiovascular Outcomes

Suzuki, Y.; Kaneko, H.; Okada, A.; Komuro, J.; Mizuno, A.; Fujiu, K.; Jo, T.; Takeda, N.; Morita, H.; Nishiyama, A.; Yano, Y.; Node, K.; Yasunaga, H.; Komuro, I.

Circulation Journal Official Journal of the Japanese Circulation Society 88(10): 1639-1646

2024

ISSN/ISBN: 1347-4820
PMID: 38569871
Accession: 091310110

Full-Text Article emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Summary
Hypertension is a major cause of cardiovascular disease (CVD). In patients with hypertension, unawareness of the disease often results in poor blood pressure control and increases the risk of CVD. However, data in nationwide surveys regarding the proportion of unaware individuals and the implications of such on their clinical outcomes are lacking. We aimed to clarify the association between unawareness of being prescribed antihypertensive medications among individuals taking antihypertensive medications and the subsequent risk of developing CVD. This retrospective cohort study analyzed data from the JMDC Claims Database, including 313,715 individuals with hypertension treated with antihypertensive medications (median age 56 years). The primary endpoint was a composite of myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation. Overall, 19,607 (6.2%) individuals were unaware of being prescribed antihypertensive medications. During the follow-up period, 33,976 composite CVD endpoints were documented. Despite their youth, minimal comorbidities, and the achievement of better BP control with a reduced number of antihypertensive prescriptions, unawareness of being prescribed antihypertensive medications was associated with a greater risk of developing composite CVD. Hazard ratios of unawareness of being prescribed antihypertensive medications were 1.16 for myocardial infarction, 1.25 for angina pectoris, 1.15 for stroke, 1.36 for heart failure, and 1.28 for atrial fibrillation. The results were similar in several sensitivity analyses, including the analysis after excluding individuals with dementia. Among individuals taking antihypertensive medications, assessing the awareness of being prescribed antihypertensive medications may help identify those at high risk for CVD-related events.

References

Kim, S.; Shin, D.W.; Yun, J.M.; Hwang, Y.; Park, S.K.; Ko, Y.-J.; Cho, B. 2016: Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization Among Patients with Newly Prescribed Antihypertensive Medications Hypertension 67(3): 506-512
Cedernaes, J.; Benedict, C. 2025: Timing of Antihypertensive Medications and Cardiovascular Outcomes JAMA 334(16): 1485-1486
Zhu, J.; Zhang, W. 2025: Timing of Antihypertensive Medications and Cardiovascular Outcomes JAMA 334(16): 1485
Gao, M.; Cao, T.; Wu, Q. 2025: Timing of Antihypertensive Medications and Cardiovascular Outcomes JAMA 334(16): 1486
Feng, S.; Li, H.; Sun, R. 2025: Timing of Antihypertensive Medications and Cardiovascular Outcomes JAMA 2025
Proschan, M.; Ford, C.E.; Cutler, J.A.; Graumlich, J.F.; Pavlik, V.; Cushman, W.C.; Davis, B.R.; Alderman, M.H.; Gordon, D.; Furberg, C.D.; Franklin, S.S.; Blumenthal, S.S.; Castaldo, R.S.; Preston, R.A. 2013: How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? Statistics in Medicine 32(5): 884-897
Zhang, K.P.; Song, Q.R.; Bai, J.J.; Cai, J. 2024: Association of intensive blood pressure management with cardiovascular outcomes in patients using multiple classes of antihypertensive medications: a post-hoc analysis of the STEP Trial Hypertension Research 47(7)
Ovbiagele, B.; Hills, N.K.; Saver, J.L.; Johnston, S.Claiborne. 2005: Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event Stroke 36(9): 1944-1947
Kothari, N.; Ganguly, B. 2015: Adherence To JNC-VII and WHO-ISH guidelines of antihypertensive medications prescribed to hypertensive patients with co-morbid conditions Indian Journal of Physiology and Pharmacology 59(1): 48-56
Suarez, A.P.; Staffa, J.A.; Fletcher, P.; Jones, J.K. 2000: Reason for discontinuation of newly prescribed antihypertensive medications: methods of a pilot study using computerized patient records Pharmacoepidemiology and Drug Safety 9(5): 405-416
Kaye, M.G.; Rutowski, J.; Aftab, H.; Pandey, R.; Khan, R.; Kalot, M.A.; Anand, R.; Graham, S.P. 2023: Screening for orthostatic hypotension in the geriatric population in a real-world primary care setting reduces prescribed antihypertensive medications Blood Pressure Monitoring 28(6): 338-342
Ebeid, W.M.; Elkady, E.F.; El-Zaher, A.A.; El-Bagary, R.I.; Patonay, G. 2014: Synchronized separation of seven medications representing most commonly prescribed antihypertensive classes by using reversed-phase liquid chromatography: Application for analysis in their combined formulations Journal of Separation Science 37(7): 748-757
Komuro, J.; Kaneko, H.; Suzuki, Y.; Okada, A.; Komuro, K.; Mizuno, A.; Fujiu, K.; Jo, T.; Takeda, N.; Morita, H.; Node, K.; Yasunaga, H.; Ieda, M.; Komuro, I. 2024: Unawareness of being prescribed medications for diabetes and incident cardiovascular disease Journal of Cardiology 84(4): 294-299
Tibebu, A.; Mengistu, D.; Bulto, L.N. 2017: Adherence to prescribed antihypertensive medications and associated factors for hypertensive patients attending chronic follow-up units of selected public hospitals in Addis Ababa, Ethiopia International Journal of Health Sciences 11(4): 47-52
Elliott, W.J. 2012: Better compliance to antihypertensive medications reduces cardiovascular risk Yearbook of Cardiology 2012: 55-57
Corrao, G.; Parodi, A.; Nicotra, F.; Zambon, A.; Merlino, L.; Cesana, G.; Mancia, G. 2011: Better compliance to antihypertensive medications reduces cardiovascular risk Journal of Hypertension 29(3): 610-618
Midy, F.; Rudnichi, A. 2013: The impact of cardiovascular profile on persistence associated with antihypertensive medications International Journal of Clinical Practice 67(12): 1334-1341
Smetana, G.W. 2012: Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk Journal of General Internal Medicine 27(6): 618-620
Hermida, R.ón.C.; Ayala, D.E.; Mojón, A.; Fernández, J.é R. 2011: Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD Journal of the American Society of Nephrology: Jasn 22(12): 2313-2321
Hogan, D.B.; Campbell, N.R.; Jennett, P.; MacLeod, N.; Brant, R. 1996: Increased use of cardiovascular medications in seniors prescribed non-ASA non-steroidal anti-inflammatory drugs Clinical and Investigative Medicine. Medecine Clinique et Experimentale 19(1): 46-54